Thomas French Whayne, Jr., M.D., Ph.D.

Connect
About
Publications

twhayn0@email.uky.edu
859-323-5479
326 C.T. Wethington Bldg, 900 S Limestone St, Lexington, KY 40536-0200
Brief
Complete

Position(s):

Professor

Affiliation(s):

Internal Medicine

Cardiovascular Research Center

Other Affiliation(s):

CVRC - Affiliated Faculty

Internal Medicine - Cardiology

PubMed Publications:

Abolbashari, M.;Macaulay, T.E.;Whayne, T.F.;Mukherjee, D.;Saha, S. "Polypharmacy in Cardiovascular Medicine: Problems and Promises!" Cardiovascular & hematological agents in medicinal chemistry (2017): [PubMed Link] | [ Full text ]
Whayne TF, J. "In Memoriam: James M. Felts, PhD." Journal of clinical lipidology (2017): [PubMed Link] |
Whayne, T.F. "Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving." Current vascular pharmacology (2017): [PubMed Link] |
Whayne TF, J. "Is There an Ideal Low-Density Lipoprotein Cholesterol Level? Confusion regarding Lipid Guidelines, Low-Density Lipoprotein Cholesterol Targets, and Medical Management." The International journal of angiology : official publication of the International College of Angiology, Inc 26, 2 (2017): 73-77. [PubMed Link] | [ Full text ]
Fisher, M.B.;Messerli, A.;Whayne TF, J. "Characteristics, Management, and Results of Out-of-Hospital Cardiac Arrest (OHCA) With or Without ST-Segment Elevation Myocardial Infarction (STEMI)." Angiology (2017): 3319717709686. [PubMed Link] | [ Full text ]
Whayne TF, J.;Morales, G.X.;Darrat, Y.H. "Clinical Aspects of Systemic Inflammation and Arrhythmogenesis, Especially Atrial Fibrillation." Angiology (2017): 3319717721399. [PubMed Link] | [ Full text ]
Whayne TF, J. "PCSK9 inhibitors in the current management of atherosclerosis." Archivos de cardiologia de Mexico 87, 1 (2017): 43-48. [PubMed Link] | [ Full text ]
Whayne, T.F. "Low-Density Lipoprotein Cholesterol (LDL-C): How Low?" Current vascular pharmacology 15, 4 (2017): 374-379. [PubMed Link] |
Whayne TF, J. "Prevention of Carotid Artery Atherosclerosis: What is the Evidence?" Angiology (2016): [PubMed Link] | [ Full text ]
Wells, G.;Whayne TF, J. "Prognosis for Women With Multivessel Coronary Artery Disease." Angiology 67, 8 (2016): 705-8. [PubMed Link] | [ Full text ]
Whayne TF, J. "Editorial : Scoring and Other Assessments of Plaque Morphology and Pathology" Angiology 67, 10 (2016): 889-893. [PubMed Link] | [ Full text ]
Whayne TF, J. "Multiple Coronary Artery Interventions." Angiology 67, 5 (2016): 427-30. [PubMed Link] | [ Full text ]
Whayne TF, J. "Statin Intolerance From a Clinician's Perspective." Angiology 67, 3 (2016): 205-7. [PubMed Link] | [ Full text ]
Saha, S.P.;Whayne TF, J. "Coenzyme Q-10 in Human Health: Supporting Evidence?" Southern medical journal 109, 1 (2016): 17-21. [PubMed Link] | [ Full text ]
Whayne TF, J. "Guideline Confusion for the Clinician." Angiology 67, 1 (2016): 5-9. [PubMed Link] | [ Full text ]
Whayne TF, J. "Renal Iodine Dye Risk, Age, and the Acute Coronary Syndrome." Angiology 67, 2 (2016): 107-12. [PubMed Link] | [ Full text ]
Whayne TF, J. "New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines." Annals of internal medicine 165, 11 (2016): 827. [PubMed Link] | [ Full text ]
Whayne TF, J. "Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia." American journal of cardiovascular drugs : drugs, devices, and other interventions 16, 2 (2016): 83-92. [PubMed Link] | [ Full text ]
Mukherjee, D.;Whayne, T.F. "Editorial (Thematic Issue: Sex, Environment, Physical Activity, Diet, and Obesity in Cardiovascular Disease Risk)." Current vascular pharmacology 14, 5 (2016): 406-408. [PubMed Link] | [ Full text ]
Whayne, T.F.;Mukherjee, D. "Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes." Current vascular pharmacology 14, 5 (2016): 458-465. [PubMed Link] | [ Full text ]
Whayne, T.F.;Saha, S.P.;Mukherjee, D. "Antioxidants in the Practice of Medicine; What Should the Clinician Know?" Cardiovascular & hematological disorders drug targets 16, 1 (2016): 13-20. [PubMed Link] | [ Full text ]